Announcement: Aurelia Bioscience has been acquired by Charnwood Molecular.

Share this

In early drug discovery, bioassays not only reveal whether a compound acts on a biological target, but also how effective it is and if it has any potentially harmful toxic effects. In turn, this can influence decisions about whether the candidate warrants further study in human clinical trials, potentially leading to its release onto the market.

The importance of bioassays in early drug discovery may be clear, yet what is less clear is how bioassays should be developed to ensure they are optimized for their specific purpose.

This eBook aims to provide you with a comprehensive guide to the key considerations involved in assay design and development, which can help to ensure the success of your research programme.

 

Download your copy